Your session is about to expire
← Back to Search
Social Robot
Social Robot for Alzheimer's Disease
N/A
Waitlist Available
Research Sponsored by DreamFace Technologies, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome.
Awards & highlights
Study Summary
This study is evaluating whether a robot can help people with Alzheimer's disease.
Eligible Conditions
- Alzheimer's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Amyloid-Beta - Alzheimer's disease
Conversation Time
Facial Expression
+5 moreSecondary outcome measures
PHQ-9
SLUMS score
Trial Design
1Treatment groups
Experimental Treatment
Group I: Robot IntervetnionExperimental Treatment1 Intervention
Participants in this Arm will interact with Ryan Companionbot.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Robot
2021
N/A
~20
Find a Location
Who is running the clinical trial?
DreamFace Technologies, LLCLead Sponsor
2 Previous Clinical Trials
28 Total Patients Enrolled
Stephanie Melgar, BSStudy DirectorUniversity of Denver/ DFT
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger